These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6435 related articles for article (PubMed ID: 25639772)
1. Establishment of a novel Chinese metastatic melanoma cell line showing the new cytogenetic and biological properties. Yi X; Zhu G; Li Y; Liu Y; Luan Q; Dai W; Wang L; Liao W; Gao T; Li C Cell Biol Int; 2015 Apr; 39(4):508-14. PubMed ID: 25639772 [TBL] [Abstract][Full Text] [Related]
2. Lymph node metastases of melanoma: challenges for BRAF mutation detection. Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT. Daniotti M; Ferrari A; Frigerio S; Casieri P; Miselli F; Zucca E; Collini P; Della Torre G; Manoukian S; Peissel B; Bono A; Santinami M; Parmiani G; Rivoltini L; Pilotti S; Rodolfo M J Invest Dermatol; 2009 Jul; 129(7):1759-68. PubMed ID: 19158841 [TBL] [Abstract][Full Text] [Related]
4. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834 [TBL] [Abstract][Full Text] [Related]
6. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status. Mitchell B; Leone D; Feller JK; Bondzie P; Yang S; Park HY; Mahalingam M Melanoma Res; 2014 Dec; 24(6):621-5. PubMed ID: 25211166 [TBL] [Abstract][Full Text] [Related]
7. Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection. Picard M; Pham Dang N; D'Incan M; Mansard S; Dechelotte P; Pereira B; Mondie JM; Barthelemy I Br J Dermatol; 2014 Jul; 171(1):108-14. PubMed ID: 24602025 [TBL] [Abstract][Full Text] [Related]
8. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity]. Xia Q; Chang XN; Huang B; Li XF; Luo DJ; Wang QJ; Jiang MT; Fan J; Zhou DW Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):837-842. PubMed ID: 39103266 [No Abstract] [Full Text] [Related]
12. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B. Soto JL; Cabrera CM; Serrano S; López-Nevot MA BMC Cancer; 2005 Apr; 5():36. PubMed ID: 15819981 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous knockdown of BRAF and expression of INK4A in melanoma cells leads to potent growth inhibition and apoptosis. Zhao Y; Zhang Y; Yang Z; Li A; Dong J Biochem Biophys Res Commun; 2008 Jun; 370(3):509-13. PubMed ID: 18402768 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of BRAF, NRAS and c-KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/IV melanoma. Knol AC; Pandolfino MC; Vallée A; Nguyen F; Lella V; Khammari A; Denis M; Puaux AL; Dréno B Exp Dermatol; 2015 Jan; 24(1):70-3. PubMed ID: 25363723 [TBL] [Abstract][Full Text] [Related]
17. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice]. Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986 [TBL] [Abstract][Full Text] [Related]
18. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells. Zhang H; Rosdahl I Int J Oncol; 2004 Feb; 24(2):331-5. PubMed ID: 14719109 [TBL] [Abstract][Full Text] [Related]
19. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944 [TBL] [Abstract][Full Text] [Related]
20. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients. Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]